![Blackhawk Resource Corp](/common/images/company/TX_BLR.png)
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates PR Newswire LEXINGTON, Mass., Nov. 14, 2022 - Pre-clinical results published in PLOS ONE...
LogicBio acquisition to build on current collaborations and advancements in genomic medicine Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to...
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine PR Newswire LEXINGTON, Mass., Oct. 3, 2022 LogicBio acquisition to build on current col...
LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE PR Newswire LEXINGTON, Mass., Sept. 21, 2022 Single intravenous administration of...
LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update PR Newswire LEXINGTON, Mass., Aug. 15, 2022 - Interim data from SUNRISE trial in four pediatric...
LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment Conference PR Newswire LEXINGTON, Mass., May 17, 2022 LEXINGTON, Mass., May 17, 2022 /PRNewswire/ -- LogicBio Therapeutics...
LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business Updates PR Newswire LEXINGTON, Mass., May 16, 2022 –FDA lifted clinical hold on SUNRISE trial in...
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting PR Newswire LEXINGTON...
LogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia PR Newswire LEXINGTON, Mass., May 9, 2022 –Company initiates activities...
LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference PR Newswire LEXINGTON, Mass., March 23, 2022 LEXINGTON, Mass., March 23, 2022 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.